2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and prasugrel hydrochloride

2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine has been researched along with prasugrel hydrochloride in 3 studies

Compound Research Comparison

Studies (2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine)	Trials (2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine)	Recent Studies (post-2010) (2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine)	Studies (prasugrel hydrochloride)	Trials (prasugrel hydrochloride)	Recent Studies (post-2010) (prasugrel hydrochloride)
32	2	15	1,803	396	1,458

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	3 (100.00)	2.80

Authors

Authors	Studies
Duconge, J; Gonzalez, AF; Gonzalez-Sepulveda, L; Hernandez-Suarez, DF; Marin-Maldonado, F; Melin, K; Naik, H; Nunez, HJ; Rivas-Tumanyan, S; Ruaño, G; Scott, SA	1
Costantini, A; Romagnoli, A; Santoleri, F	1
Harris, J; Johnson, TW; Lasserson, D; Loke, YK; Mahadevan, K; Mumford, A; Pouwels, K; Pufulete, M; Reeves, BC	1

Trials

2 trial(s) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and prasugrel hydrochloride

Article	Year
Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial. BMJ open, 2020, 08-06, Volume: 10, Issue:8 Topics: Acute Coronary Syndrome; Algorithms; Caribbean Region; Dinucleoside Phosphates; Hispanic or Latino; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Treatment Outcome	2020
Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'targe Open heart, 2022, Volume: 9, Issue:2 Topics: Acute Coronary Syndrome; Adolescent; Aspirin; Clopidogrel; Cohort Studies; Dinucleoside Phosphates; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor	2022

Article

Year

Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial.

BMJ open, 2020, 08-06, Volume: 10, Issue:8

Topics: Acute Coronary Syndrome; Algorithms; Caribbean Region; Dinucleoside Phosphates; Hispanic or Latino; Humans; Percutaneous Coronary Intervention; Pharmacogenetics; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Treatment Outcome

2020

Real-world bleeding in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and prescribed different combinations of dual antiplatelet therapy (DAPT) in England: a population-based cohort study emulating a 'targe

Open heart, 2022, Volume: 9, Issue:2

Topics: Acute Coronary Syndrome; Adolescent; Aspirin; Clopidogrel; Cohort Studies; Dinucleoside Phosphates; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; ST Elevation Myocardial Infarction; Ticagrelor

2022

Other Studies

1 other study(ies) available for 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine and prasugrel hydrochloride

Article	Year
Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient education and counseling, 2021, Volume: 104, Issue:8 Topics: Acute Coronary Syndrome; Clopidogrel; Dinucleoside Phosphates; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Retrospective Studies; Treatment Outcome	2021